Technology

Russian Scientist Aims to put Gene-Edited Embryos in HIV-Positive Mothers

Not a day goes by in the medical world without some new discoveries or developments. In Russia, one scientist claims he will produce gene-edited children. As horrific as that may sound, he would not be the first individual to explore this option. Given the overall negative stance toward gene editing and CRISPR, this controversial research will spark some intriguing debates.

Gene-edited Babies on Demand?

While there may very well be some merit to CRISPR in human trials. It is not something most people expect to see for quite some time to come. The current consensus among scientists is how such experiments need to be banned until an ethical framework has been put in place. For now, such a framework does not exist, nor is there a sign of one being created. As such, the following claims by a Russian scientist need to be taken with a grain of salt.

Denis Rebrikov might not be a name too many readers are familiar with. That is only normal, albeit that may change a lot sooner than originally anticipated. He claims he will implant gene-edited embryos into women. These embryos would be treated with CRISPR. It is expected Rebrikov will receive official approval for these experiments before the year 2019 comes to a close. A rather optimistic view but stranger things have happened.

It is not the first time such outlandish claims are made. Last year, He Jiankui claimed he effectively “created” the world’s first CRISPS babies. While those claims have still not been officially verified, it seems there is a genuine interest among fringe scientists to explore human trials with CRISPR, regardless of the overall ethical concerns.

Related Post

According to Rebrikov, the procedure will be rather straightforward. His intention is to target the CCR5 gene, but with a slight twist. His approach will – allegedly -introduce fewer risks and greater benefits. More importantly, he claims the procedure is ethically justifiable, which will always remain a topic of debate. In his vision, he will disable the CCR5 gene in embryos which will be “grown” by HIV-positive mothers. In doing so, he aims to ensure the baby cannot become HIV-positive.

There are several key aspects of this research which will raise many eyebrows. Perhaps the most worrisome aspect is how Rebrikov seemingly has an agreement with a local HIV center to recruit women infected with HIV. This is despite the technology not being ready for human trials, as well as the ethical concerns which arise. Putting an end to these trials – if they ever occur in the first place – may not necessarily be as easy as one may think.

At this time, most countries maintain a blanket ban on implanted gene-edited embryos. Russia is, depending on how one wants to interpret the current regulations, not one of those countries. Instead, the current rules leave a bit of a gray area which can be exploited by radical scientists like Rebrikov. It will be interesting to see if he will obtain his license, and if so, whether his experiments will prove successful. Gene-editing is still a very new science, with a lot of potential risks attached to it.

JP Buntinx

JP Buntinx is a FinTech and Bitcoin enthusiast living in Belgium. His passion for finance and technology made him one of the world's leading freelance Bitcoin writers, and he aims to achieve the same level of respect in the FinTech sector.

Share
Published by
JP Buntinx

Recent Posts

Justin Sun Pledges $SUN Buybacks With SunPerp Revenue

Justin Sun, CEO of TRON DAO, has just made one of his biggest announcements of…

2 days ago

$BNB Hits $1,000 ATH as Market Cap Reaches $145.7B

$BNB has broken through a historic milestone. The token surged past $1,000, setting a new…

3 days ago

Top 5 DeFi Tokens Less Than $1 Price Mark To Watch In September

Decentralized finance (DeFi) has continued to disrupt traditional financial systems, offering permissionless access to lending,…

3 days ago

Solana Data Insights: App Revenues Hit $193.5M in August, Up 126% YoY

Solana’s app economy posted another breakout month. Total application revenues surged to $193.5 million in…

4 days ago

Sharps Technology Aligns with Bonk for Treasury Staking and Solana Growth

Sharps Technology (NASDAQ: STSS) is making a major move in the Solana ecosystem. The company,…

4 days ago

Understand AR In the Context of LivLive’s Game Layer for Reality Ecosystem

LivLive is redefining augmented reality (AR) gaming by turning real-world actions into measurable value for…

5 days ago